These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3925837)

  • 1. Selection of the dominant ovarian follicle and hormonal enhancement of the natural cycle.
    Hodgen GD; Kenigsburg D; Collins RL; Schenken RS
    Ann N Y Acad Sci; 1985; 442():23-37. PubMed ID: 3925837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiology of the menstrual cycle].
    Pricop M
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):347-61. PubMed ID: 3937195
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiology of the menstrual cycle.
    Owen JA
    Am J Clin Nutr; 1975 Apr; 28(4):333-8. PubMed ID: 1091131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid metabolism and follicular development in the ovary.
    Hillier SG
    Oxf Rev Reprod Biol; 1985; 7():168-222. PubMed ID: 3001616
    [No Abstract]   [Full Text] [Related]  

  • 5. Asymmetrical ovarian function during recruitment and selection of the dominant follicle in the menstrual cycle of the rhesus monkey.
    diZerega GS; Marut EL; Turner CK; Hodgen GD
    J Clin Endocrinol Metab; 1980 Oct; 51(4):698-701. PubMed ID: 6774990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folliculogenesis in the primate ovarian cycle.
    diZerega GS; Hodgen GD
    Endocr Rev; 1981; 2(1):27-49. PubMed ID: 6795034
    [No Abstract]   [Full Text] [Related]  

  • 7. The interovarian progesterone gradient: a spatial and temporal regulator of folliculogenesis in the primate ovarian cycle.
    diZerega GS; Hodgen GD
    J Clin Endocrinol Metab; 1982 Mar; 54(3):495-9. PubMed ID: 6799537
    [No Abstract]   [Full Text] [Related]  

  • 8. The primate ovarian cycle: suppression of human menopausal gonadotropin-induced follicular growth in the presence of the dominant follicle.
    diZerega GS; Hodgen GD
    J Clin Endocrinol Metab; 1980 May; 50(5):819-25. PubMed ID: 6768758
    [No Abstract]   [Full Text] [Related]  

  • 9. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypophyseal-ovarian relations in the process of formation of the ovulatory cycle in girls].
    Savchenko ON; Mel'nikova MM; Sokolov EG; Stepanov GS; Streltsova NA
    Akush Ginekol (Mosk); 1974 Aug; 0(8):1-6. PubMed ID: 4409752
    [No Abstract]   [Full Text] [Related]  

  • 11. [The ovarian follicle].
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14 Suppl():13-8. PubMed ID: 3930593
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulatory and inhibitory effects of progesterone on follicular development in the hypophysectomized follicle-stimulating hormone/luteinizing hormone-treated hamster.
    Kim I; Greenwald GS
    Biol Reprod; 1987 Mar; 36(2):270-6. PubMed ID: 3107623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women.
    Ditkoff EC; Cassidenti DL; Paulson RJ; Sauer MV; Paul WL; Rivier J; Yen SS; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1811-7. PubMed ID: 1750480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of lead follicle diameter to initiate gonadotropin-releasing hormone antagonist does not affect in vitro fertilization clinical pregnancy, implantation, or live birth rates: a prospective, randomized study.
    Dayal MB; Frankfurter D; O'Hern C; Peak D; Dubey A; Gindoff PR
    Fertil Steril; 2009 Dec; 92(6):2047-9. PubMed ID: 19591990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Of eggs and follicles.
    Greenwald GS
    Am J Anat; 1972 Sep; 135(1):1-3. PubMed ID: 4627011
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endocrine control of the menstrual cycle].
    Wildt L; Leyendecker G
    Gynakologe; 1981 Jun; 14(2):64-83. PubMed ID: 6790358
    [No Abstract]   [Full Text] [Related]  

  • 17. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian contractility.
    Coutinho EM; Maia H; Maia H
    Basic Life Sci; 1974; 4(PT. B):127-37. PubMed ID: 4376687
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.